DTC（消費者向け）遺伝子検査市場：検査タイプ別、技術別、エンドユーザー別、地域別、2024年～2031年

DTC（消費者向け）遺伝子検査市場の評価、2024年～2031年

DTC（消費者向け）遺伝子検査市場が急成長しています。個人に合わせたヘルスケアやウェルネスへの関心が高まっています。消費者は自分の健康についてより積極的に考えるようになっており、DTC検査はその人固有の遺伝子構成に関する情報を提供します。この知識は、栄養、運動、さらには病気予防法に関しても、その人特有の生物学的特徴に合わせたアプローチで、十分な情報に基づいた決定を下すのに役立ちます。様々な組織が市場規模を牽引し、2024年には14億3,000万米ドルを超え、2031年には約38億6,000万米ドルの評価額に達します。

さらに、遺伝子疾患に対する意識の高まりと予防措置への注目が、DTC検査の需要を促進しています。費用対効果が高く効率的なDTC（消費者向け）遺伝子検査に対する需要の高まりが、2024年から2031年にかけてCAGR13.25%での市場成長を可能にしています。

DTC（消費者向け）遺伝子検査市場：定義／概要

DTC（消費者向け）遺伝子検査とは、ヘルスケア専門家の関与なしに消費者に直接販売される検査を指します。これらの検査は、しばしば人のDNAを評価し、家系、遺伝形質、特定の疾患に対する遺伝的素因、場合によっては治療反応を判定します。DTC遺伝子検査を提供する会社は通常、消費者にキットを届け、消費者はDNAサンプル（通常は唾液）を採取し、分析のために会社に返送します。結果はしばしばオンラインまたはモバイルアプリで入手可能で、しばしば解釈や推奨を伴う。

DTC遺伝子検査は、その簡便さと、個人の健康状態や遺伝について得られる可能性のある洞察により、人気が高まっています。消費者は、アルツハイマー、ガン、心臓病などの病気に対する自分の遺伝的素因について興味を持っており、ライフスタイルの選択に影響を与えたり、積極的なヘルスケア決定を促したりする可能性があります。もう一つの人気のあるアプリケーションは、人々が自分の遺伝的遺産についてもっと知り、遠い親戚とつながることを可能にする先祖の検査です。

全ゲノム配列決定の低コスト化などの技術の進歩により、これらの検査が提供する情報の精度と範囲が向上する可能性があります。電子カルテや開業医との統合により、臨床現場における遺伝データの解釈や利用が改善されるかもしれないです。しかし、解釈の正確性、遺伝子データのプライバシー、センシティブな健康情報を直接入手することによる潜在的な心理的影響については、懸念が残る。DTC遺伝子検査の規制と監視は、消費者が有用な遺伝学的知見へのアクセスを維持しながら、これらの懸念に対応するように進化する可能性が高いです。

消費者意識の高まりがDTC（消費者向け）遺伝子検査市場をどのように牽引しているか？

消費者の知識の増加は、DTC（消費者向け）遺伝子検査市場の主な促進要因です。より多くの個人が、自分の健康リスクを理解し、治療を最適化し、教育されたライフスタイルを選択するための潜在的な利点を認識するようになるにつれて、遺伝子検査サービスに対する需要は増加すると予想されます。啓発キャンペーン、教育イニシアティブ、メディア報道は、消費者直接DNA検査（DTC）の入手可能性、価格、入手しやすさについて一般大衆に注意を喚起する上で極めて重要です。このような認知度の向上は、新規顧客の獲得によって市場を拡大するだけでなく、現在の利用者が、家系やオーダーメイドのウェルネス・プログラムなど、他の遺伝的洞察を調査する動機付けとなり、市場の成長を後押しします。

国立医学図書館によると、DTC（消費者向け）遺伝子検査は、ヘルスケア専門家の関与なしに、通常はインターネットを通じて消費者に直接販売されます。この検査は、好意的な注目も否定的な注目も集めています。2008年、『タイム』誌は、23andMeのDTC全ゲノムスキャンを「イノベーション・オブ・ザ・イヤー」に選びました。DTC遺伝子検査のウェブサイトは、科学的研究にリンクしていることが多く、ユーザーフォーラムのような双方向機能を含んでいることもあります。2012年、一般的な検査費用は数百ドルだった。2011年、23andMe社は10万件のフルゲノムスキャンを販売したと報告しています。

個別化ヘルスケアとウェルネスの動向の高まり、個別化ヘルスケアとウェルネスに焦点が移るにつれ、DTC遺伝子検査のニーズは拡大しています。消費者は、より多くの情報に基づいたライフスタイル、病気の予防、治療の決定をするために、自分の遺伝的構成を理解することにますます興味を持つようになっています。DTC遺伝子検査は、その人固有の遺伝子プロファイルに関する重要な情報を提供し、健康に対してより個別化されたアプローチをとることを可能にするので、個人はDTC遺伝子検査から利益を得ています。

規制と倫理的懸念はDTC（消費者向け）遺伝子検査市場の成長に影響を与えるか？

DTC（消費者向け）遺伝子検査市場の規制と倫理的配慮は、拡大に大きな影響を与える可能性があります。遺伝子検査所見の正確性、解釈、報告に関する異なる要件などの規制上の困難は、市場参入と拡大を阻害する可能性があります。プライバシー保護と遺伝子データの安全な保存に関する不確実性は、消費者の不信と規制上の懸念を増大させる。

遺伝情報の適切な使用と解釈に関する倫理的問題、消費者への潜在的な心理的影響、遺伝的差別に関する懸念はすべて、市場力学を複雑にしています。透明性のある方法、強力なデータ保護措置、効果的な規制の枠組みを通じてこれらの懸念に対処することは、顧客の信頼を確立し、DTC遺伝子検査市場での長期的な成功を保証するために不可欠です。

DNAの共有は倫理的・プライバシー的懸念をもたらします。消費者は、DTC企業が違法なアクセスを得たり、データ侵害を犯したり、自分の遺伝情報を悪用したりすることを懸念しており、これが市場の成長を阻害する可能性があります。コストと償還の問題DTC検査は高額であり、保険の適用範囲も限られている場合があります。これは多くの見込み顧客にとって参入障壁となりうる。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 DTC（消費者向け）遺伝子検査市場：検査タイプ別

• キャリア検査
• 予測検査
• 家系・血縁検査
• ニュートリゲノミック検査

第5章 DTC（消費者向け）遺伝子検査市場：技術別

• ターゲット分析
• 一塩基多型（SNP）チップ
• 全ゲノムシーケンス（WGS）

第6章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第7章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第8章 競合情勢

• 主要企業
• 市場シェア分析

第9章 企業プロファイル

• 23andMe
• Ancestry
• Color Genomics
• Helix
• Living DNA
• EasyDNA
• Full Genome Corporation
• Genesis Healthcare
• Family Tree DNA（Gene By Gene）
• MyHeritage

第10章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第11章 付録

• 略語リスト
• 出典と参考文献

Direct-To-Consumer (DTC) Genetic Testing Market Valuation - 2024-2031

The market for direct-to-consumer (DTC) genetic testing is growing rapidly. There is an increasing interest in individualized healthcare and wellness. Consumers are becoming more proactive about their health, and DTC testing provides information about their unique genetic composition. This knowledge can help people make informed decisions regarding nutrition, exercise, and even disease-preventive techniques, adapting their approach to their particular biology. The various organizations is driving the market size to surpass USD 1.43 Billion in 2024 to reach a valuation of aroundUSD 3.86 Billion by 2031.

Furthermore, rising awareness of genetic disorders and a focus on preventative measures are driving demand for DTC testing. The rising demand for cost-effective and efficient direct-to-consumer (DTC) genetic testing is enabling the market grow at aCAGR of 13.25% from 2024 to 2031.

Direct-To-Consumer (DTC) Genetic Testing Market: Definition/ Overview

Direct-to-consumer (DTC) genetic testing refers to tests that are sold directly to consumers without the involvement of healthcare experts. These tests often evaluate a person's DNA to determine ancestry, inherited traits, genetic predispositions to particular diseases, and, in some cases, treatment reactions. Companies that provide DTC genetic testing typically deliver a kit to the consumer, who then collects a DNA sample (usually saliva) and returns it to the company for analysis. Results are often made available online or via a mobile app and are frequently accompanied by interpretations and recommendations.

DTC genetic testing has grown in popularity due to its simplicity and the possible insights it provides about personal health and heritage. Consumers are curious about their genetic predispositions to diseases such as Alzheimer's, cancer, and heart disease, which could influence lifestyle choices or encourage proactive healthcare decisions. Another popular application is ancestry testing, which allows people to learn more about their genetic heritage and connect with distant relatives.

Technological advancements, such as the lower cost of whole genome sequencing, may improve the accuracy and range of information offered by these tests. Integration with electronic health records and medical practitioners may improve the interpretation and use of genetic data in clinical settings. However, worries persist about the accuracy of interpretations, the privacy of genetic data, and the potential psychological consequences of getting sensitive health information directly. Regulation and monitoring of DTC genetic testing will most likely evolve to meet these concerns while maintaining consumer access to useful genetic insights.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How Increasing Consumer Awareness Driving the Direct-To-Consumer (DTC) Genetic Testing Market?

Increasing consumer knowledge is a major driver of the Direct-to-Consumer (DTC) genetic testing market. Demand for genetic testing services is expected to increase as more individuals become aware of its potential benefits for understanding their health risks, optimizing medical treatments, and making educated lifestyle choices. Awareness campaigns, educational initiatives, and media coverage are critical in alerting the public about the availability, price, and accessibility of direct-to-consumer DNA testing (DTC). This increased awareness not only broadens the market by hiring new customers but also motivates current users to investigate other genetic insights, such as ancestry and tailored wellness programs, thus boosting market growth.

According to the National Library of Medicine, Direct-to-consumer (DTC) genetic tests are sold directly to consumers, without the involvement of a healthcare professional, usually through the Internet. The tests have garnered both favorable and negative attention. In 2008, Time Magazine dubbed 23andMe's DTC whole genome scan the 'Innovation of the Year.' DTC genetic testing websites frequently link to scientific studies and may include interactive features like user forums. In 2012, the typical cost for the testing was several hundred dollars. In 2011, 23andMe reported that the company had sold 100,000 full genome scans.

Increasing Personalized Healthcare and Wellness Trends, the need for DTC genetic testing is expanding as the focus shifts to personalized healthcare and wellness. Consumers are becoming increasingly interested in understanding their genetic makeup to make more informed lifestyle, disease preventive, and treatment decisions. Individuals benefit from DTC genetic testing because it provides significant information about their unique genetic profile, allowing them to take a more personalized approach to their health.

Will Regulatory and Ethical Concerns Impact the Growth of the Direct-to-Consumer (DTC) Genetic Testing Market?

The Direct-to-Consumer (DTC) genetic testing market regulatory and ethical considerations could have a substantial impact on the expansion. Regulatory difficulties, such as different requirements for the accuracy, interpretation, and reporting of genetic test findings, might impede market entry and expansion. Uncertainties about privacy protections and the secure storage of genetic data add to consumer distrust and regulatory concerns.

Ethical difficulties regarding the proper use and interpretation of genetic information, potential psychological effects on consumers, and worries about genetic discrimination all complicate market dynamics. Addressing these concerns through transparent methods, strong data protection measures , and effective regulatory frameworks will be essential for establishing customer trust and guaranteeing long-term success in the DTC genetic testing market.

Sharing DNA poses ethical and privacy concerns. Consumers are concerned about DTC companies gaining illegal access, committing data breaches, or misusing their genetic information, which might impede market growth. Cost and Reimbursement Issues DTC testing is expensive, and insurance coverage may be limited. This can be a barrier to entrance for many prospective clients.

Category-Wise Acumens

Will Heritage and Familial Connections Propel the Ancestry & Relationship Testing Segment for the Direct-to-Consumer (DTC) Genetic Testing Market?

The Direct-to-Consumer (DTC) genetic testing market, the Ancestry & Relationship Testing section is fueled by a strong desire to learn about one's ancestors and family relationships. Ancestry & Relationship Testing dominates the DTC genetic testing market. Many people are very interested in learning about their genetic ancestry, discovering ancestral roots, and connecting with distant relatives. This fascination stems from a combination of personal interest in family history, cultural identification, and the compelling narratives supplied by genealogy. Furthermore, the capacity to find unknown relatives and create family trees using shared genetic data increases the appeal of these services.

The fastest-growing area is expected to be nutrigenomic testing. This part is aimed at a health-conscious audience interested in improving their diet and wellness depending on their genetic composition. As consumers become more aware of the link between genes and diet, they are looking for individualized information to help them improve their health. This area is expected to develop as there is a greater emphasis on preventative measures and a proactive approach to wellbeing.

Will Cost-Effectively Signify the Single Nucleotide Polymorphism (SNP) Chips for the Direct-to-Consumer (DTC) Genetic Testing Market?

In the realm of DTC genetic testing technology, Single Nucleotide Polymorphism (SNP) Chips currently reign supreme. Cost-effectiveness is a key factor driving the use of Single Nucleotide Polymorphism (SNP) chips in the Direct-to-Consumer (DTC) genetic testing market. SNP chips are a very inexpensive means of studying genetic variants across an individual's genome, making them available to a larger user base. These chips allow for the detection of a wide range of genetic markers associated with health, characteristics, and ancestry at a lower cost than whole-genome sequencing. The low cost of SNP chip technology enables DTC genetic testing companies to provide comprehensive genetic insights at a mass market price point, resulting in widespread adoption and market growth.

Whole Genome Sequencing (WGS) may reign supreme in terms of rapid expansion. WGS provides the most thorough analysis by understanding an individual's full genetic code. While more expensive than SNP chips, WGS has enormous potential for future uses. As technology becomes more inexpensive and data interpretation methods improve, WGS is expected to gain popularity. This is owing to its ability to detect a broader spectrum of genetic variants and perhaps provide a more complete picture of a person's health risk.

Country/Region-wise Acumens

Will the High Concentration of Direct-to-Consumer (DTC) Genetic Testing Market Propel the North America?

In the DTC genetic testing market, North America now enjoys a strong position. The high concentration of the Direct-to-Consumer (DTC) genetic testing market is expected to stimulate growth in North America. The region's modern healthcare infrastructure, high consumer awareness, and large disposable income all contribute to a high demand for genetic testing services.

Furthermore, the presence of major direct-to-consumer genetic testing companies, as well as supporting legislative frameworks and substantial technology innovations, contribute to market expansion. North America's leadership in genomics research and innovation is also critical to driving the adoption and development of direct-to-consumer genetic testing, making it a vital market for growth in this sector.

A big population with disposable income is interested in personalized medicine. Furthermore, North America has a strong culture of preventative healthcare and genetic awareness, which drives market growth.

Will Increasing Internet Penetration Lead the Asian Pacific to the Direct-to-Consumer (DTC) Genetic Testing Market?

The baton of quickest growth is going to be passed to the Asia Pacific region. The growing internet penetration is an essential component of the Direct-to-Consumer (DTC) genetic testing market in Asia-Pacific. As internet availability expands, particularly in emerging nations, more people will be able to research and purchase DTC genetic testing services online. The simplicity of accessing information, ordering tests, and receiving results via digital platforms makes genetic testing more accessible to a greater audience.

This region is experiencing a convergence of forces fueling market expansion. Rising disposable income, increased internet penetration, and increased health and wellness consciousness are creating a fertile field for direct-to-consumer genetic testing. Furthermore, numerous Asian countries have large, young populations who are particularly open to innovative technologies and individualized healthcare techniques. This, combined with a fast-rising healthcare infrastructure, is projected to propel the business forward in this region.

Competitive Landscape

The Direct-To-Consumer (DTC) Genetic Testing Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Direct-To-Consumer (DTC) Genetic Testing Market include:

• EasyDNA
• Ancestry

23andMe, Inc.

• Color Health, Inc.
• Genesis HealthCare
• Full Genomes Corporation, Inc.
• Helix OpCo LLC
• Living DNA Ltd
• Mapmygenome
• GenomeWeb
• Gene by Gene, Ltd.
• MyHeritage Ltd.

10x Genomics

• Dante Labs, Inc.

24Genetics

• Laboratory Corporation of America Holdings
• Myriad Genetics, Inc.
• Quest Diagnostics Incorporated
• Uniogen Oy

Latest Developments

• In April 2023, Genesis Healthcare Co.'s GeneLife brand launched Haplo 3.0 in Japan, marking a significant advance to its ancestry services.
• In July 2023, Quest Diagnostics debuted its first DTC-GT, Genetic Insights. The test analyzes a saliva sample to determine the risk of up to 24 genetically inheritable diseases, including colon and breast cancer, blood and heart issues, cystic fibrosis carrier status, sickle cell anemia, and Tay-Sachs disease.
• In January 2022, 23andMe Holding Co., a prominent consumer genetics and research firm, was granted FDA approval for a genetic health risk report on a hereditary prostate cancer marker.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type

• Carrier Testing
• Predictive Testing
• Ancestry & Relationship Testing
• Nutrigenomic Testing

5. Direct-To-Consumer (DTC) Genetic Testing Market, By Technology

• Targeted Analysis
• Single Nucleotide Polymorphism (SNP) Chips
• Whole Genome Sequencing (WGS)

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• 23andMe
• Ancestry
• Color Genomics
• Helix
• Living DNA
• EasyDNA
• Full Genome Corporation
• Genesis Healthcare
• Family Tree DNA (Gene By Gene)
• MyHeritage

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References